<?xml version="1.0" encoding="UTF-8"?>
<p>In a recent meta-analysis for the prevalence of HBVr in rheumatic diseases being treated with conventional or biologic agents, the pooled HBVr estimate was 1.4%, thus much lower than the relevant estimation in hematology/oncology.
 <sup>
  <xref rid="bibr16-1759720X20912646" ref-type="bibr">16</xref>
 </sup>
</p>
